FDA Clearance Tracker · P830055-S265
LCS Total Knee System
Last checked: Nov 20, 2026Latest source record: May 10, 2021 (this decision)Source: openFDAMethods & limitations
Decided
May 10, 2021
Approved
Time to decision
24 days
Received Apr 16, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P830055-S265
- Device name
- LCS Total Knee System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Apr 16, 2021
- Decided
- May 10, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Johnson & Johnson Medical (DePuy Suzhou) Ltd., No. 299, Changyang Street, Suzhou Industrial Park, Suzhou Jiangsu, China, to manufacture ATTUNE CR and ATTUNE PS Femoral Components of the LCS Total Knee System.
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.